Kidney Cancer

Kidney Cancer Stage Migrated Downward in Low Income Patients After ACA

By

Natasha Persaud

Publish Date February 19, 2021

Higher proportions of patients in the low to middle income brackets were diagnosed with localized renal cell carcinoma in states allowing Medicaid expansion.

Cabozantinib Prolongs PFS in Papillary Renal Cell Carcinoma

Publish Date February 18, 2021

Progression-free survival longer and response rate greater for cabozantinib versus sunitinib in phase 2 trial in adults with PRCC.

COVID-19 Adversely Affecting Patients With Genitourinary Cancers

By

Jody A. Charnow

Publish Date February 17, 2021

In an online survey, 17.2% of patients with genitourinary cancers reported they delayed or avoided seeking medical care because of the COVID-19 pandemic.

Palliative Care Use in Advanced Renal Cell Carcinoma Linked to Socioeconomic Groups

By

Jessica Nye, PhD

Publish Date February 15, 2021

Researchers sought to determine accessibility and use of palliative care among patients with advanced renal cell carcinoma.

Nivolumab/Cabozantinib Prolongs OS in Advanced RCC With Sarcomatoid Features

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date February 12, 2021

CheckMate 9ER investigators assessed the efficacy of combination nivolumab and cabozantinib in the front-line sarcomatoid renal cell carcinoma (RCC) setting in an extended analysis.